FDA Approved: LOTEPREDNOL ETABONATE — Supplemental Application (ARMAS PHARMACEUTICALS INC.)

View source ↗

Summary

FDA approves a supplemental application for Loteprednol Etabonate from Armas Pharmaceuticals Inc. under ANDA 212080, finalizing the status of the generic ophtha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Inflammation
• Seasonal Allergic Conjunctivitis

Drugs mentioned

• LOTEPREDNOL ETABONATE (Loteprednol etabonate)

Snippet

SUPPL AP for LOTEPREDNOL ETABONATE (LOTEPREDNOL ETABONATE)